Physicochemical Properties
| Molecular Formula | C25H27N4O2I.HCL |
| Molecular Weight | 578.87242 |
| Exact Mass | 578.095 |
| CAS # | 220643-77-6 |
| Related CAS # | 220643-77-6 (HCl);155204-23-2; |
| PubChem CID | 11957651 |
| Appearance | White to off-white solid powder |
| Boiling Point | 657.5ºC at 760 mmHg |
| Flash Point | 351.4ºC |
| Vapour Pressure | 3.66E-17mmHg at 25°C |
| LogP | 4.968 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Heavy Atom Count | 33 |
| Complexity | 578 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4=CC=C(C=C4)I.Cl |
| InChi Key | PBPBIDMIRMWUCI-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C25H27IN4O2.ClH/c1-32-23-7-3-2-6-22(23)29-17-14-28(15-18-29)16-19-30(24-8-4-5-13-27-24)25(31)20-9-11-21(26)12-10-20;/h2-13H,14-19H2,1H3;1H |
| Chemical Name | 4-iodo-N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylbenzamide;hydrochloride |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | p-MPPI hydrochloride exhibits no agonist action in presynaptic and postsynaptic 5-HT1A receptor activity tests conducted in vitro and in vivo [1]. |
| ln Vivo | In the elevated plus maze, mice treated with p-MPPI hydrochloride (0.5-4.5 mg/kg; intraperitoneal) exhibit anxiolytic-like effects [2]. |
| Animal Protocol |
Animal/Disease Models: Adult male Swiss Webster mice (8-9 weeks) [2] Doses: 0.5, 1.5, 4.5 mg/kg Route of Administration: intraperitoneal (ip) injection Experimental Results: Significant and significant effects on conventional (open arm avoidance) Dose-related anxiolytic effects and behavioral (risk assessment) measures. |
| References |
[1]. Sørensen E, et al. The selective 5-HT(1A) receptor antagonist p-MPPI antagonizes sleep--waking and behavioural effects of 8-OH-DPAT in rats. Behav Brain Res. 2001 Jun;121(1-2):181-7. [2]. Cao BJ, et al. Anxiolytic-like profile of p-MPPI, a novel 5HT1A receptor antagonist, in the murine elevated plus-maze. Psychopharmacology (Berl). 1997 Feb;129(4):365-71. |
Solubility Data
| Solubility (In Vitro) |
DMSO : ~17.86 mg/mL (~30.85 mM) H2O : ~3.33 mg/mL (~5.75 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.79 mg/mL (3.09 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 17.9 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1.79 mg/mL (3.09 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 17.9 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 1.79 mg/mL (3.09 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 17.9 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.7275 mL | 8.6375 mL | 17.2750 mL | |
| 5 mM | 0.3455 mL | 1.7275 mL | 3.4550 mL | |
| 10 mM | 0.1728 mL | 0.8638 mL | 1.7275 mL |